🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Radiation therapy is emerging as a frontline hero in attacking some of the most aggressive enemies in the cancer world. Leading the revolution with groundbreaking research are physician-investigators at Baptist Health Miami Cancer Institute. baptisthealth.net/baptist-health…

🎥Today at #ASCO25, we spoke with Dr Manmeet Ahluwalia (Manmeet Ahluwalia, MD, MBA, FASCO) on the pivotal S1609 basket trial exploring nivolumab + ipilimumab in rare cancer brain metastases 🧠 ➡️Full interview coming soon on VJOncology.com⬅️ ASCO #ImmunoOnc #BTSM

Thrilled to attend #ASCO25 and represent oral medicine in oncology! Join us! 🔬 [1] meetings.asco.org/abstracts-pres… [2] meetings.asco.org/abstracts-pres… #OralCancer #Oncology Miami Cancer Institute Research Baptist Health

We’re live at #ASCO25 and ready for the poster presentations! Our researchers are presenting pivotal poster data on glioblastoma, breast cancer, brain metastases, and more!

💡 Dr. Rupesh Kotecha Rupesh Kotecha shares key findings on ADORATION, a phase I/II study combining azeliragon with SRS in patients with brain metastases. Could this novel approach enhance therapeutic response? #ASCO25

Dr. Zouina Sarfraz shares a meta-analysis on machine learning models for glioma classification. 🧠 ML models showed strong diagnostic performance (sensitivity: 83%, specificity: 78%), but high heterogeneity limits clinical use. #ASCO25 #AIinMedicine #Glioma #NeuroOnc

Kudos to Dr. Manmeet Ahluwalia Manmeet Ahluwalia, MD, MBA, FASCO for presenting research on the multi-center trial LIMITLESS, a pivotal study using microbubble-enhanced transcranial ultrasound to treat NSCLC brain metastases. This novel approach may redefine noninvasive drug delivery in

•Day 1 Recap• Attended ‘Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies’— an insightful CME session with big strides expected ahead! 🧬🧠 #ASCO2025 Manmeet Ahluwalia, MD, MBA, FASCO Azza Sarfraz, MBBS Fatma Nihan Akkoc Mustafayev

Honored and grateful to have presented my first poster at the ASCO Annual Meeting 2025 — an opportunity made possible through the invaluable mentorship of Dr. Ahluwalia and the incredible support of our entire team! #ASCO25 #Glioma #AI

Dr. Fatma Akkoc Mustafayev shares national data on cancer trends and survival among adolescent and young adult (AYA) patients, highlighting the need for earlier detection and age-adapted screening strategies to address this growing challenge. #ASCO25 #AYAOncology

💡 Dr. Arelis Martir-Negron presents new research on the prevalence and diversity of BRCA1/2 pathogenic variants in South Florida’s Hispanic population. 📊 5.2% carried a BRCA1/2 P/LP variant—most in BRCA2 (68.2%)—including unique variants in patients of Cuban, Nicaraguan &

Congratulations to Dr. Sarbajit Mukherjee (Sarbajit Mukherjee), our new Chief of GI Medical Oncology, for presenting an oral abstract on neoadjuvant strategies in biliary tract cancer. 🍍👏 We look forward to advancing these approaches in future clinical trials. #ASCO25

We’re proud to see Miami Cancer Institute Research researchers paving the way for more inclusive databases and equitable access to precision oncology. #ASCO25 Well done! 🍍👏

📍Live from #ASCO25: Our team is energized and ready for today’s powerful plenary sessions—driving forward the breakthroughs that will redefine cancer care. 🍍💡

In this "Beat the Clock" segment, Manmeet Ahluwalia, MD, MBA, FASCO of Miami Cancer Institute Research, goes #OntheClock ⏱️ with Dr Chandler Park of @mednewsweek to discuss the key data he is most excited about at this year's ASCO Annual Meeting/ #ASCO25 Check back on hubs.li/Q03q4HSM0 for more.

#ASCO25 GAIN Trial: Neoadjuvant #Gemcitabine/cisplatin nearly doubled median OS to 27.8 months vs 14.6 months with adjuvant therapy in resectable #BiliaryTractCancer. R0 resection rates: 62.5% vs. 33.3%. bit.ly/3FIkPhf #BTC Frankfurt Cancer Institute Sarbajit Mukherjee Miami Cancer Institute Research

We’re honored to celebrate Zouina Sarfraz, MBBS (Zouina Sarfraz), recipient of a 2025 Conquer Cancer, the ASCO Foundation Merit Award for her rigorous evaluation of SRN risk in HER2+ breast cancer brain mets. Her findings reveal a consistent increase in SRN with concurrent ADC + RT—key data for future

From brainstorming sessions in the clinic to the ASCO stage—what a journey it’s been! Watching my mentees present at #ASCO25 was a proud and emotional moment. Keep chasing bold ideas Yu Fujiwara, MD Deepak Vadehra Supriya peshin Baptist Health Cancer Care Miami Cancer Institute Research Roswell Park Hematology/Oncology Fellowship UB Internal Medicine

June is Cancer Survivors Month, a time to honor strength, resilience, and life beyond treatment. At Baptist Health Cancer Care, our Survivorship Program supports every step of the journey forward. 💚 baptisthealth.net/baptist-health…

💡Reshma Mahtani discusses pivotal #ASCO25 presentations that may shape #breastcancer standard of care cancernetwork.com/view/pivotal-p… via CancerNetwork® #bcsm